Vickers 2019 - Step-by-Step Guide to Decision Curve Analysis - Overview

Summary

Vickers, Van Calster and Steyerberg (2019, Diagnostic and Prognostic Research 3:18, open access CC BY 4.0) explain decision curve analysis (DCA), introduced by Vickers and Elkin (2006), by relabelling its axes: y is benefit and x is preference. A model or test is worth using if it has the highest net benefit across the range of clinically reasonable preferences. Key takeaway: net benefit is in units of true positives per patient, with false positives converted by the odds of the threshold probability.

Overview

Problem. DCA is widely cited (over 1000 citations by May 2019) and endorsed by JAMA, BMJ, Annals of Internal Medicine, JCO and PLoS Medicine editorials, yet widely misunderstood; the paper reports that a well-respected epidemiologist said he had found only a couple of people who could explain what decision curves mean.

Contribution. A didactic five-step reading of one decision curve (a hypothetical prostate-biopsy study) plus answers to ten common questions. It deliberately does not teach how to compute curves (“readers are referred to … Vickers and Elkin [1] … and www.decisioncurveanalysis.org”).

Key results.

  • Net benefit , with the odds at the threshold probability.
  • A threshold of 10% means “missing a high-grade cancer is 9 times worse than doing an unnecessary biopsy” and a number-needed-to-test of 10.
  • A net benefit of 0.07 means “7 true positives for every 100 patients”.
  • Do not pick a threshold from the curve; fix the reasonable range first, then compare strategies over it.

Motivating PyMC examples

From https://redam94.github.io/pymc-challenges/examples.html:

  • E90 - Call it today or wait? Hospital thresholds, nowcasts and decision curves. A nowcast is turned into a call-or-wait rule at hospital capacity thresholds, and strategies (call today, wait for more data, treat-all, treat-none) are compared with decision curves. The threshold probability plays the role of the harm/benefit exchange rate in this paper.
  • E91 and E87 use the same logic of pricing a decision rule against the do-nothing and do-everything strategies.

Main Content

Source Map

Paper sectionContentCovered in
Abstract, Introduction (pp. 1-2)Aim, net benefit definition, citation contextthis note and Vickers 2019 - Net Benefit and Threshold Probability
Example setup (p. 2)Prostate biopsy, prevalence 10%, test (40%/90%), model AUC 0.79; Fig. 1Vickers 2019 - Five-Step Interpretation and Prostate Biopsy Example
Step 1 Benefit is good (p. 3)Strategies: model, test, all, none; “intervention” definedVickers 2019 - Five-Step Interpretation and Prostate Biopsy Example
Step 2 Preference (p. 3-4)“Worried about disease” to “worried about biopsy” axissame
Step 3 Threshold probability (p. 4)Odds, number-needed-to-test, Fig. 2, plausible range up to 20%Vickers 2019 - Net Benefit and Threshold Probability
Step 4 Net benefit (p. 4)Net profit analogy; units are true positivesVickers 2019 - Net Benefit and Threshold Probability
Step 5 Interventions avoided (p. 4-5)Net reduction in unnecessary interventions; Fig. 3Vickers 2019 - Five-Step Interpretation and Prostate Biopsy Example
Questions 1-10 (pp. 5-7)Threshold unknown, treatment effect, size of difference, CIs, AUC vs NB, all/none, replacing CEA, choosing thresholds, clinic use, individual thresholdsVickers 2019 - Ten Questions and Limits of Decision Curves
Conclusion, Abbreviations, declarationsPubMed counts 311 vs 95 (2017)Vickers 2019 - Ten Questions and Limits of Decision Curves

Examples

See the verified numbers for the paper’s setup in Vickers 2019 - Five-Step Interpretation and Prostate Biopsy Example.

Connections

See Also